240 related articles for article (PubMed ID: 21915626)
21. A highly infectious Plasmodium yoelii parasite, bearing Plasmodium falciparum circumsporozoite protein.
Zhang M; Kaneko I; Tsao T; Mitchell R; Nardin EH; Iwanaga S; Yuda M; Tsuji M
Malar J; 2016 Apr; 15():201. PubMed ID: 27068454
[TBL] [Abstract][Full Text] [Related]
22. Immunogenicity of Ty-VLP bearing a CD8(+) T cell epitope of the CS protein of P. yoelii: enhanced memory response by boosting with recombinant vaccinia virus.
Oliveira-Ferreira J; Miyahira Y; Layton GT; Savage N; Esteban M; Rodriguez D; Rodriguez JR; Nussenzweig RS; Zavala F
Vaccine; 2000 Mar; 18(17):1863-9. PubMed ID: 10699335
[TBL] [Abstract][Full Text] [Related]
23. Preclinical efficacy and immunogenicity assessment to show that a chimeric Plasmodium falciparum UB05-09 antigen could be a malaria vaccine candidate.
Dinga JN; Gamua SD; Ghogomu SM; Titanji VPK
Parasite Immunol; 2018 Mar; 40(3):. PubMed ID: 29284177
[TBL] [Abstract][Full Text] [Related]
24. Strategy for development of a pre-erythrocytic Plasmodium falciparum DNA vaccine for human use.
Hoffman SL; Doolan DL; Sedegah M; Aguiar JC; Wang R; Malik A; Gramzinski RA; Weiss WR; Hobart P; Norman JA; Margalith M; Hedstrom RC
Vaccine; 1997 Jun; 15(8):842-5. PubMed ID: 9234529
[TBL] [Abstract][Full Text] [Related]
25. CD4(+) T-cell- and gamma interferon-dependent protection against murine malaria by immunization with linear synthetic peptides from a Plasmodium yoelii 17-kilodalton hepatocyte erythrocyte protein.
Charoenvit Y; Majam VF; Corradin G; Sacci JB; Wang R; Doolan DL; Jones TR; Abot E; Patarroyo ME; Guzman F; Hoffman SL
Infect Immun; 1999 Nov; 67(11):5604-14. PubMed ID: 10531206
[TBL] [Abstract][Full Text] [Related]
26. Passive immunization with a multicomponent vaccine against conserved domains of apical membrane antigen 1 and 235-kilodalton rhoptry proteins protects mice against Plasmodium yoelii blood-stage challenge infection.
Narum DL; Ogun SA; Batchelor AH; Holder AA
Infect Immun; 2006 Oct; 74(10):5529-36. PubMed ID: 16988228
[TBL] [Abstract][Full Text] [Related]
27. Mice immunised with synthetic peptide from N-terminal conserved region of merozoite surface antigen-2 of human malaria parasite Plasmodium falciparum can control infection induced by Plasmodium yoelii yoelii 265BY strain.
Lougovskoi AA; Okoyeh NJ; Chauhan VS
Vaccine; 1999 Dec; 18(9-10):920-30. PubMed ID: 10580206
[TBL] [Abstract][Full Text] [Related]
28. Isolation and Characterization of Vaccine Candidate Genes Including
Kim SH; Bae YA; Seoh JY; Yang HJ
Korean J Parasitol; 2017 Jun; 55(3):255-265. PubMed ID: 28719950
[TBL] [Abstract][Full Text] [Related]
29. Fc receptors are not required for antibody-mediated protection against lethal malaria challenge in a mouse model.
Rotman HL; Daly TM; Clynes R; Long CA
J Immunol; 1998 Aug; 161(4):1908-12. PubMed ID: 9712060
[TBL] [Abstract][Full Text] [Related]
30. Plasmodium yoelii blood-stage antigens newly identified by immunoaffinity using purified IgG antibodies from malaria-resistant mice.
Kamali AN; Marín-García P; Azcárate IG; Diez A; Puyet A; Bautista JM
Immunobiology; 2012 Aug; 217(8):823-30. PubMed ID: 22658767
[TBL] [Abstract][Full Text] [Related]
31. Characterization of the merozoite surface protein 4/5 gene of Plasmodium berghei and Plasmodium yoelii.
Kedzierski L; Black CG; Coppel RL
Mol Biochem Parasitol; 2000 Jan; 105(1):137-47. PubMed ID: 10613706
[TBL] [Abstract][Full Text] [Related]
32. Protection of mice against Plasmodium yoelii sporozoite challenge with P. yoelii merozoite surface protein 1 DNA vaccines.
Becker SI; Wang R; Hedstrom RC; Aguiar JC; Jones TR; Hoffman SL; Gardner MJ
Infect Immun; 1998 Jul; 66(7):3457-61. PubMed ID: 9632624
[TBL] [Abstract][Full Text] [Related]
33. Identification and characterization of the Plasmodium yoelii PyP140/RON4 protein, an orthologue of Toxoplasma gondii RON4, whose cysteine-rich domain does not protect against lethal parasite challenge infection.
Narum DL; Nguyen V; Zhang Y; Glen J; Shimp RL; Lambert L; Ling IT; Reiter K; Ogun SA; Long C; Holder AA; Herrera R
Infect Immun; 2008 Nov; 76(11):4876-82. PubMed ID: 18710865
[TBL] [Abstract][Full Text] [Related]
34. Comparison of protection induced by immunization with recombinant proteins from different regions of merozoite surface protein 1 of Plasmodium yoelii.
Tian JH; Kumar S; Kaslow DC; Miller LH
Infect Immun; 1997 Aug; 65(8):3032-6. PubMed ID: 9234750
[TBL] [Abstract][Full Text] [Related]
35. Immunization with a functional protein complex required for erythrocyte invasion protects against lethal malaria.
Srinivasan P; Ekanem E; Diouf A; Tonkin ML; Miura K; Boulanger MJ; Long CA; Narum DL; Miller LH
Proc Natl Acad Sci U S A; 2014 Jul; 111(28):10311-6. PubMed ID: 24958881
[TBL] [Abstract][Full Text] [Related]
36. Synthetic peptides based on conserved Plasmodium falciparum antigens are immunogenic and protective against Plasmodium yoelii malaria.
Chauhan VS; Chatterjee S; Johar PK
Parasite Immunol; 1993 Apr; 15(4):239-42. PubMed ID: 7685076
[TBL] [Abstract][Full Text] [Related]
37. Tricomponent immunopotentiating system as a novel molecular design strategy for malaria vaccine development.
Miyata T; Harakuni T; Tsuboi T; Sattabongkot J; Ikehara A; Tachibana M; Torii M; Matsuzaki G; Arakawa T
Infect Immun; 2011 Oct; 79(10):4260-75. PubMed ID: 21807905
[TBL] [Abstract][Full Text] [Related]
38. Immunization with a combination of merozoite surface proteins 4/5 and 1 enhances protection against lethal challenge with Plasmodium yoelii.
Kedzierski L; Black CG; Goschnick MW; Stowers AW; Coppel RL
Infect Immun; 2002 Dec; 70(12):6606-13. PubMed ID: 12438332
[TBL] [Abstract][Full Text] [Related]
39. Immunogenicity of Plasmodium yoelii merozoite surface protein 4/5 produced in transgenic plants.
Wang L; Webster DE; Campbell AE; Dry IB; Wesselingh SL; Coppel RL
Int J Parasitol; 2008 Jan; 38(1):103-10. PubMed ID: 17681344
[TBL] [Abstract][Full Text] [Related]
40. Subpatent infection with nucleoside transporter 1-deficient Plasmodium blood stage parasites confers sterile protection against lethal malaria in mice.
Aly AS; Downie MJ; Mamoun CB; Kappe SH
Cell Microbiol; 2010 Jul; 12(7):930-8. PubMed ID: 20088947
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
